Pharmaceutical product permissions
A searchable record of what Walter is equipped to evaluate.
Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.
5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes
Built for portfolio teams
Move from a molecule search to a focused feasibility conversation.
The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.
Search the catalogue ↓How to read this catalogue
Permission is a starting point—not a supply commitment.
01Therapeutic index
Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.
02Facility confirmation
Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.
03Product feasibility
Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.
04Responsible use
This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.
Regulatory note
Records are presented as an indicative manufacturing-permissions reference, not prescribing or dispensing advice. Where shown, a Drugs Rules flag is a conservative screening indicator, and a Schedule H caution label is not a claim of Schedule H list membership. A CDSCO category is displayed only where the composition, strength and dosage form match a filing reference. Availability, current approval status, exact schedule position, exemptions, applicable unit, licence scope, formulation, claims, brand use, destination-market registration and commercial feasibility remain subject to documentary verification and Walter’s written confirmation.
